clinical trials

News

Tris Pharma has set its sights on an FDA filing for non-opioid pain drug cebranopadol this year after hitting the mark in an abdominoplasty trial.

R&D

The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and

News

Novo Nordisk's high-dose version of semaglutide boosts its weight-loss ability, but it still can't match its main rival in the obesity market.

News

Boehringer Ingelheim's bid to develop the first drug therapy for impaired cognitive function in schizophrenia looks like it has reached an end.

R&D

Partner Content

The AAPS National Biotechnology Conference uncovers the trends driving today’s biotech markets.

News

Adverse events have led Keros to abandon a phase 2 trial of pulmonary arterial hypertension drug cibotacept, a would-be rival to MSD's Winrevair.